Home Mf Research Mirae Asset Nifty 500 Healthcare Etf Regular Plan Growth
Mirae Asset Mutual Fund

Mutual Fund Research

Mirae Asset Nifty 500 Healthcare ETF - Regular Plan - Growth

Mirae Asset Mutual Fund Others Others Etf

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,039.80 +3.98%
Two Week 2026-10-19 ₹1,000.00 ₹1,066.06 +6.61%
One Month 2026-10-05 ₹1,000.00 ₹1,035.82 +3.58%
Three Months 2026-08-05 ₹3,000.00 ₹3,036.68 +1.22%
Six Months 2026-05-07 ₹6,000.00 ₹6,227.39 +3.79%
Since Inception 2026-02-10 ₹9,000.00 ₹9,756.26 +8.40%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 77.80%
Healthcare Services 21.69%
Healthcare Equipment & Supplies 0.47%
Other 0.03%

Top Holdings

Company-wise portfolio exposure

Sun Pharmaceutical Industries Ltd. 10.13%
Divi's Laboratories Ltd. 8.76%
Apollo Hospitals Enterprise Ltd. 6.24%
Laurus Labs Ltd. 5.72%
Cipla Ltd. 5.62%
Dr. Reddy's Laboratories Ltd. 5.58%
Torrent Pharmaceuticals Ltd. 5.24%
Max Healthcare Institute Ltd. 5.13%
Lupin Ltd. 3.66%
Aurobindo Pharma Ltd. 3.43%
Fortis Healthcare Ltd. 2.98%
Glenmark Pharmaceuticals Ltd. 2.61%
Alkem Laboratories Ltd. 2.31%
Zydus Lifesciences Ltd. 2.14%
Mankind Pharma Ltd. 2.10%
IPCA Laboratories Ltd. 1.98%
Biocon Ltd. 1.91%
Gland Pharma Ltd. 1.71%
Sai Life Sciences Ltd. 1.56%
Krishna Institute of Medical Sciences Ltd. 1.48%
Aster DM Quality Care Ltd. 1.38%
Neuland Laboratories Ltd. 1.36%
Wockhardt Ltd. 1.30%
Acutaas Chemicals Ltd. 1.26%
Ajanta Pharma Ltd. 1.22%
Dr. Lal Path labs Ltd. 1.15%
Abbott India Ltd. 1.04%
Piramal Pharma Ltd. 0.95%
Granules India Ltd. 0.93%
Narayana Hrudayalaya Ltd. 0.92%
Global Health Ltd. 0.90%
Onesource Specialty Pharma Ltd. 0.89%
Glaxosmithkline Pharmaceuticals Ltd. 0.85%
Anthem Biosciences Ltd. 0.69%
Emcure Pharmaceuticals Ltd. 0.60%
Natco Pharma Ltd. 0.55%
Cohance Lifesciences Ltd. 0.54%
Vijaya Diagnostic Centre Ltd. 0.52%
Syngene International Ltd. 0.51%
Rainbow Children's Medicare Ltd. 0.49%
Polymedicure Ltd. 0.47%
Rubicon Research Ltd. 0.43%
Caplin Point Laboratories Ltd. 0.40%
Concord Biotech Ltd. 0.34%
TREPS 0.13%
Net Receivables / (Payables) -0.09%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
N/A
Return volatility
β
Beta
N/A
Benchmark sensitivity
S
Sharpe Ratio
N/A
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity
Risk ratio figures are currently unavailable for this scheme. Explanations below are for reference.

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Fund Family

Compare schemes from Mirae Asset Mutual Fund by performance, fundamentals and risk.

Returns are historical and do not guarantee future performance.

View All Mirae Asset Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

An open-ended scheme replicating/tracking Nifty 500 Healthcare Total Return Index

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
0.35%
Expense Ratio (Direct)
N/A
Lock-in Period
N/A
Fund Age
N/A
Benchmark
Nifty 500 Healthcare (TRI)

Exit Load

Charges that may apply when you redeem units

N/A

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?